Warning! GuruFocus detected
3 Severe warning signs
with AZT.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
ArcticZymes Technologies ASA
ISIN : NO0010014632
Compare
Compare
Traded in other countries / regions
AZT.NorwayBIOTECO.Sweden0DRV.UKB4V.Germany IPO Date
2005-11-04Description
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 30.12 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 1.54 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 27.36 | |||||
| Beneish M-Score | -1.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -6.8 | |||||
| 3-Year EBITDA Growth Rate | -56.4 | |||||
| 3-Year EPS without NRI Growth Rate | -45.6 | |||||
| 3-Year Book Growth Rate | 9.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 67.77 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 17.38 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.28 | |||||
| 9-Day RSI | 39.1 | |||||
| 14-Day RSI | 44.74 | |||||
| 3-1 Month Momentum % | 41.99 | |||||
| 6-1 Month Momentum % | 4.21 | |||||
| 12-1 Month Momentum % | -35.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.23 | |||||
| Quick Ratio | 16.28 | |||||
| Cash Ratio | 14.74 | |||||
| Days Inventory | 841.79 | |||||
| Days Sales Outstanding | 61.55 | |||||
| Days Payable | 311.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | 0.23 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 94.27 | |||||
| Operating Margin % | -1.27 | |||||
| Net Margin % | 7.26 | |||||
| FCF Margin % | -7.44 | |||||
| ROE % | 2.39 | |||||
| ROA % | 2.22 | |||||
| ROIC % | -0.89 | |||||
| 3-Year ROIIC % | -299.11 | |||||
| ROC (Joel Greenblatt) % | -2.19 | |||||
| ROCE % | -0.41 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 121.99 | |||||
| Forward PE Ratio | 82.44 | |||||
| PE Ratio without NRI | 121.99 | |||||
| Shiller PE Ratio | 88.28 | |||||
| PS Ratio | 8.71 | |||||
| PB Ratio | 2.7 | |||||
| Price-to-Tangible-Book | 2.96 | |||||
| Price-to-Operating-Cash-Flow | 550.93 | |||||
| EV-to-EBIT | -470.04 | |||||
| EV-to-Forward-EBIT | 312.1 | |||||
| EV-to-EBITDA | 118.81 | |||||
| EV-to-Forward-EBITDA | 78.03 | |||||
| EV-to-Revenue | 5.98 | |||||
| EV-to-Forward-Revenue | 5.25 | |||||
| EV-to-FCF | -86.33 | |||||
| Price-to-GF-Value | 0.58 | |||||
| Price-to-Projected-FCF | 1.84 | |||||
| Price-to-Median-PS-Value | 0.82 | |||||
| Price-to-Graham-Number | 3.98 | |||||
| Price-to-Net-Current-Asset-Value | 3.25 | |||||
| Price-to-Net-Cash | 3.85 | |||||
| Earnings Yield (Greenblatt) % | -0.2 | |||||
| FCF Yield % | -0.89 | |||||
| Forward Rate of Return (Yacktman) % | -17.45 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ArcticZymes Technologies ASA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 104.373 | ||
| EPS (TTM) (kr) | 0.14 | ||
| Beta | -0.27 | ||
| 3-Year Sharpe Ratio | -0.75 | ||
| 3-Year Sortino Ratio | -0.92 | ||
| Volatility % | 51.75 | ||
| 14-Day RSI | 44.74 | ||
| 14-Day ATR (kr) | 0.941208 | ||
| 20-Day SMA (kr) | 17.972 | ||
| 12-1 Month Momentum % | -35.95 | ||
| 52-Week Range (kr) | 12.34 - 29.7 | ||
| Shares Outstanding (Mil) | 51.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ArcticZymes Technologies ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ArcticZymes Technologies ASA Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
ArcticZymes Technologies ASA Frequently Asked Questions
What is ArcticZymes Technologies ASA(OSL:AZT)'s stock price today?
The current price of OSL:AZT is kr16.84. The 52 week high of OSL:AZT is kr29.70 and 52 week low is kr12.34.
When is next earnings date of ArcticZymes Technologies ASA(OSL:AZT)?
The next earnings date of ArcticZymes Technologies ASA(OSL:AZT) is 2025-05-08.
Does ArcticZymes Technologies ASA(OSL:AZT) pay dividends? If so, how much?
ArcticZymes Technologies ASA(OSL:AZT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers